• PT and aPTT
  • Dengue Virus NS1 Antigen
  • Malaria/Babesia Blood Smear
  • Spinocerebellar Ataxia, Ataxin 8 (ATXN8OS) Gene Mutation Analysis
  • Human Immunodeficiency Virus 2 (HIV-2) DNA/RNA Qualitative or Quantitative
  • Arylsulfatase A (ARSA) Mutation Analysis, Molecular Methods
  • Hereditary hemorrhagic telangiectasia
  • Inflammatory bowel disease
  • Iron deficiency anemia
  • Neuroendocrine Neoplasms (Carcinoid Tumors)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

Additional ICD10
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.
Loading...